Previous 10 | Next 10 |
Home DNA testing services provider 23andMe ( DNA ) plans to terminate 100 people, 14% of its workforce, in response to weakening sales. Most of the cuts will affect operations teams that were focused on growth and scaling efforts. More news on: 23andMe, Anixa Biosciences, Inc., Guardant ...
I Don’t Feel Comfortable in Info and Data Tech at These Levels My go-to “fast-Money trades” are the chips, software and Internet-enabled business stocks. I understand the underlying economics, and that gives me the comfort to be aggressive when conditions call for it...
REDWOOD CITY, Calif., Jan. 21, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) a leading precision oncology company, has appointed Kumud Kalia as the company’s new Chief Information Officer (CIO). Among his responsibilities, he will lead the company’s enterprise ap...
The following slide deck was published by Guardant Health, Inc. in conjunction with this Read more ...
REDWOOD CITY, Calif., Jan. 13, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), announces a strategic collaboration to develop and help support commercialization of a blood-based companion diagnostic (CDx) test for Amgen’s AMG 510, an investigational oral therapy th...
REDWOOD CITY, Calif. and PITTSBURGH, Pa., Jan. 12, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, and NRG Oncology, a National Cancer Institute (NCI) funded National Clinical Trials Network group conducting clinical and translational resea...
Shares of Guardant Health (NASDAQ: GH) rose nearly 108% last year, according to data provided by S&P Global Market Intelligence . In its first full year on the market, the liquid biopsy specialist easily outperformed the 28.8% gain of the S&P 500 in 2019. While the s...
We're only nine days into the new year, but it's likely that many new year's resolutions have already been broken. Wait a few more weeks and months, and many more resolutions will fall by the wayside. However, there's one resolution for 2020 that many investors should make and stick to: Buy mor...
10x Genomics (NASDAQ: TXG ) initiated with Buy rating and $100 (32% upside) price target at Citigroup. More news on: 10x Genomics, Inc., AbbVie Inc., AdaptHealth Corp., Healthcare stocks news, Stocks on the move, , Read more ...
A new year is here. And so are new opportunities to profit from healthcare stocks . Three healthcare stocks that look like smart picks to buy in January are Axsome Therapeutics (NASDAQ: AXSM) , Guardant Health (NASDAQ: GH) , and Intuitive Surgical (NASDAQ: ISRG) . Here's why the...
News, Short Squeeze, Breakout and More Instantly...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will present data from two real-world studies at the 2024 Digestive Disease Week (DDW) meeting in Washington, DC, highlighting the value of the company’s Shield™ test in colorectal cancer (C...
2024-05-11 09:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Revenue growth of 31% driven by strong clinical and biopharma volume and Guardant360 ASP tailwinds Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today reported financial results for the quarter ended March 31, 2024. First Quarter 2024 Financial Highligh...